The effect of mechanical ventilation to acute exacerbation of IPF and CTD-ILD

医学 恶化 CTD公司 回顾性队列研究 内科学 特发性肺纤维化 机械通风 队列 间质性肺病 海洋学 地质学
作者
Yingmin Ma,Liu Yang,Jing Wang,Yuhan Hu,Yijie Zhang,Jie Sun
出处
期刊:European Respiratory Journal 被引量:1
标识
DOI:10.1183/1393003.congress-2017.pa3809
摘要

Background: The mechanism of acute exacerbation of ILD has not been elucidated thoroughly, and no effective therapy in clinic has yet been developed. Patients often need to be hospitalized in RICU with mechanical ventilation (MV) treatment. A retrospective cohort study was designed to assess the efficacy on patients with acute exacerbation of idiopathic pulmonary fibrosis (IPF)and connective tissue disease-ILD(CTD-ILD) treated with MV in RICU. Methods: A retrospective analysis was made on the clinical data of patients in RICU who suffered from acute exacerbation of IPF or CTD-ILD in three teaching hospitals in Beijing during Jan 1st, 2011 to Dec 31st, 2015. The patients were divided into two groups according to diseases, and their epidemiological characteristics, MV mode parameters and prognosis were compared. Results: The cohort consisted of 58 patients (37 males and 21 females) with a median age of 70 (61~78). Age, gender, APACHⅡscore, oxygenation index, number of noninvasive/invasive MV mode, duration of noninvasive/invasive MV time and hospitalization time between two groups had no significant statistical difference. However, in-hospital mortality rates of the groups of acute exacerbation of IPF and CTD-ILD in RICU were 97% and 76% respectively, and there was a statistically significant difference between the two groups (X2 =5.894,P=0.035). Conclusions The therapeutic efficacy of MV on acute exacerbation of IPF and CTD-ILD varied significantly. The morality rate of AE-IPF was extremely high while the acute exacerbation of CTD-ILD has relatively moderate outcome. Invasive MV did not improve the survival rate in both groups. We advise no invasive MV treatment should be utilized to both groups in RICU.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
传奇3应助彩色子轩采纳,获得10
刚刚
马昌进发布了新的文献求助10
1秒前
undo完成签到 ,获得积分10
3秒前
可爱的函函应助weiqi采纳,获得10
4秒前
5秒前
顾矜应助piers采纳,获得10
5秒前
积极小懒虫完成签到,获得积分10
6秒前
wyyt完成签到,获得积分10
6秒前
水冰冰完成签到 ,获得积分10
7秒前
FashionBoy应助水123采纳,获得10
7秒前
tudou0210发布了新的文献求助20
8秒前
我是老大应助Weilang采纳,获得30
8秒前
隐形不凡完成签到,获得积分10
9秒前
踏实沂完成签到 ,获得积分10
9秒前
yangdoudou关注了科研通微信公众号
12秒前
lansing完成签到 ,获得积分10
12秒前
Li完成签到,获得积分10
14秒前
量子星尘发布了新的文献求助10
15秒前
结实天川发布了新的文献求助10
16秒前
微笑完成签到,获得积分10
17秒前
充电宝应助1234567采纳,获得10
18秒前
李桂芳完成签到,获得积分10
20秒前
拽而不狂完成签到,获得积分10
20秒前
花汀酒完成签到 ,获得积分10
21秒前
是真的宇航员啊完成签到,获得积分10
22秒前
23秒前
23秒前
文艺的懿完成签到,获得积分10
25秒前
水123发布了新的文献求助10
28秒前
匡杰嘉发布了新的文献求助10
28秒前
29秒前
29秒前
山长子完成签到,获得积分10
30秒前
清爽的诗槐完成签到,获得积分10
31秒前
拽而不狂发布了新的文献求助10
33秒前
swan完成签到 ,获得积分10
33秒前
34秒前
愤怒的连虎完成签到,获得积分20
34秒前
Amber发布了新的文献求助10
35秒前
善学以致用应助WYH采纳,获得10
35秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Clinical Microbiology Procedures Handbook, Multi-Volume, 5th Edition 临床微生物学程序手册,多卷,第5版 2000
人脑智能与人工智能 1000
King Tyrant 720
Silicon in Organic, Organometallic, and Polymer Chemistry 500
Peptide Synthesis_Methods and Protocols 400
Principles of Plasma Discharges and Materials Processing, 3rd Edition 400
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5603927
求助须知:如何正确求助?哪些是违规求助? 4688787
关于积分的说明 14856110
捐赠科研通 4695468
什么是DOI,文献DOI怎么找? 2541034
邀请新用户注册赠送积分活动 1507185
关于科研通互助平台的介绍 1471832